期刊文献+

近10年血培养分析及血中719株常见细菌的耐药性 被引量:33

Blood Culture and Antimicrobial Resistance of 719 Strains of Bacteremia in Recent 10 Years: Analysis of Results
下载PDF
导出
摘要 目的了解我院10年来血培养的送检、检出以及血中常见细菌的药敏情况,指导临床对菌血症的治疗。方法利用WHONET5.2和EXCEL软件分析细菌分布、种类变化及纸片扩散药敏数据。结果我院自1994年1月~2003年11月30日共送检血液培养标本15262份,平均分离阳性率为8.1%,其中细菌1130株占91.0%;真菌9.0%;在凝固酶阴性葡萄球菌和金黄色葡萄球菌中MRSCN和MRSA分别为71.7%和36.4%,目前未发现对万古霉素耐药的葡萄球菌、粪肠球菌和屎肠球菌,但有8.7%、1.7%的屎肠球菌、粪肠球菌处于中介;血中产ESBLs的克雷伯菌和大肠埃希菌分别为15%和24.8%,在阴沟肠杆菌、克雷伯菌和大肠埃希菌中,克雷伯菌对环丙沙星的敏感性最高75%;铜绿假单胞菌和不动杆菌对阿米卡星、环丙沙星和头孢他啶耐药性较低,分别为2.0%、19.2%;9.8%、19.2%和11.8%、23.1%;有17.6%的铜绿假单胞菌对亚胺培南耐药,目前没有对亚胺培南耐药的阴沟肠杆菌、克雷伯菌、大肠埃希菌和不动杆菌。结论目前我院菌血症仍以革兰阴性菌为主,引起菌血症的种类不同耐药性差异较大,及时了解血培养结果对临床有针对性地抗菌治疗提供依据,降低病死率,提高治愈率。 OBJECTIVE To evaluate the method of blood culture and to understand the resistance trend of ~commonly isolated bacteria. METHODS The data of bacterial distribution and antimicrobial susceptibility from 1994 to 2002 were analyzed by WHONET5.2 and EXCEL software. RESULTS The six major pathogens isolated from blood were Escherichia coli, coagulase-negative Staphylococcus, Pseudomonas aeruginosa, Enterococcus, ~S. aureus, Klebsiella pneumoniae, respectively, in recent 10 years. MRCNS and MRSA were 71.7% and 36.4% among coagulase-negative staphylococci and S. aureus. None of the Staphylococcus and Enterococcus showed ~resistance to vancomycin. 1.7% of E. faecalis and 8.7% of E. faecium, however, showed intermediate ~resistance to vancomycin. ESBLs-producing K. pneumoniae and ESBLs-producing E. coli were 15% and ~24.8%. In Gram negative rods the resistance of K. pneumoniae to ciprofloxacin was the lowest, which was ~25.5%. The resistance rate of P. aeruginosa and Acinetobacter spp, showed 2% and 19.2% to amikacin; 9.8% and 19.2% to ciprofloxacin; 11.8% and 23.1% to ceftazidime, respectively. None of the Enterobacter and Acinetobacter spp showed resistance to imipenem. But the resistance of P. aeruginosa to imipenem was 17.6%. CONCLUSIONS The major pathogens isolated from blood were Gram negative rods in our hospital in recent ~10 years. It is different resistance of difference strains giving rise to bacteremia. Clinical physician ought to ~understand the characteristics, select antimicrobial agents correctly and efficiently, and enhance rate of cure of ~bacteremia.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2005年第1期92-95,共4页 Chinese Journal of Nosocomiology
关键词 菌血症 抗生素 耐药性 Bacteremia Antibiotics Drug resistance
  • 相关文献

参考文献5

  • 1陈民钧.细菌对β-内酰胺药的耐药性及检测方法[J].中华检验医学杂志,2001,24(4):197-200. 被引量:161
  • 2佘丹阳,刘又宁.AmpC酶和超广谱β-内酰胺酶在阴沟肠杆菌中的表达及对其耐药性的影响[J].中华医学杂志,2002,82(19):1355-1358. 被引量:86
  • 3National Committee for Clinical Laboratory Standards. Perfor-mance standards for antimicrobial disk susceptibility tests[S].6th ed. Approved standard M2 A6 (M100-S7). Wayne:NCCLS, 2002.
  • 4Horii T, Suzuki Y, Monji A, et al. Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mu-tations on fluoroquinolone MICs [J]. Diagn Microbiol Infect Dis, 2003,46(2) : 139-145.
  • 5Eveillard M, Schmit JL, Eb F. Antimicrobial use prior to the acquisition of multiresistant bacteria[J]. Infect Control Hosp Epidemiol, 2002,23(3) : 155-158.

二级参考文献12

  • 1Livermore DM, Williams JD. β-lactams: mode of action and mechanisms of bacterial resistance. In: Lorian V, eds. Antibiotics in laboratory medicine. 4th ed. Baltimore:Williams & Wilkins, 1996. 502-578.
  • 2Sanders CC. β-lactamase of gram negative bacteria: new challenges for new drugs. Clin Infect Dis, 1992,14:1089-1099.
  • 3Naumiuk L, Samet A, Dziemaszkiewicz E. Cefepime in vitro activity against derepressed extended-spectrum β-lactamase(ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method. J Antimicrob Chemother, 2001,48:321-322.
  • 4National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th informational supplement(M100-S9). Wayne:NCCLS,1999.
  • 5Coudron PE,Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol, 2000, 38:1791-1796.
  • 6Tzelepi E, Giakkoupi P, Sofianou D, et al. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol, 2000,38:542-546.
  • 7Chanal C, Sirot D, Romaszko JP, et al. Survey of extended-spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother, 1996, 38:127-132.
  • 8Coudron PE,Moland ES, Sanders CC. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol, 1997, 35:2593-2597.
  • 9吴伟元,陈民钧,王辉.阴沟肠杆菌去阻遏持续高产AmpC酶和超广谱β-内酰胺酶(ESBLs)的检测[J].中国临床药理学杂志,2001,17(2):104-109. 被引量:201
  • 10俞云松,陈亚岗,周伟琳,马亦林.一种新基因型SHV-28 β-内酰胺酶的发现及其特性的初步研究[J].中华检验医学杂志,2001,24(4):204-206. 被引量:37

共引文献242

同被引文献208

引证文献33

二级引证文献247

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部